Cardiac Resynchronisation Therapy (CRT) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Cardiac Resynchronisation Therapy Market Report Overview
The Cardiac Resynchronisation Therapy (CRT) market size was valued at $3.28 billion in 2023. The market is anticipated to grow at a CAGR of more than 5% from 2023 to 2033. CRT device is used to treat heart failure-induced conduction disturbances and ventricular dyssynchrony. When used in combination with stable, optimal medical therapy, CRT is designed to reduce symptoms and improve cardiac function by restoring the mechanical sequence of ventricular activation and contraction.
CRT Market Outlook, 2023-2033 ($ Billion)
Buy the Full Report for More Insights into the CRT Market Forecast, Download a Free Report Sample
The CRT market research report is built to visualize quantitative market trends within the cardiovascular devices therapeutic area. It discusses in detail the impact of COVID-19 on the CRT market for the year 2020 and beyond. The report will help companies develop and design in-licensing and out-licensing strategies by reviewing pipeline products and technologies.
Market Size (2023) | $3.28 billion |
CAGR (2023-2033) | >5% |
Forecast period | 2023-2033 |
Historical Period | 2015-2023 |
Key Regions |
|
Key Segments | · Cardiac Resynchronisation Therapy – Defibrillators (CRT-D)
· Wireless – Cardiac Resynchronisation Therapy (Wireless-CRT) · Cardiac Resynchronisation Therapy – Pacemakers (CRT-P) |
Leading Companies | · Medtronic Plc
· Abbott Laboratories · Boston Scientific Corp · Biotronik SE & Co KG · MicroPort Scientific Corp · EBR Systems Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
CRT Market Dynamics
The global prevalence of Heart Failure (HF) is one of the major drivers for CRT. Most CRT markets will experience steady growth over the forecast period due to a rise in aging populations, increasing awareness in emerging markets, growth in medical tourism in developing countries, and decreasing morbidity and mortality rates with the use of CRT devices. Additionally, product innovations such as wireless pacing devices are expected to drive the market in the forecast period.
CRT Market by Segments
The key segments in the CRT market are Cardiac Resynchronisation Therapy – Defibrillators (CRT-D, Wireless – Cardiac Resynchronisation Therapy (Wireless-CRT), Cardiac Resynchronisation Therapy – Pacemakers (CRT-P). The choice of CRT implant is dependent on various factors like age, sex, etc. In 2023, the CRT-D segment accounted for the highest share of the market.
Cardiac resynchronisation therapy – defibrillator (CRT-D) uses an implantable cardioverter defibrillator (ICD) to improve the coordination of the heart rhythm. This device utilizes three leads, one to the right atrium and one in each of the ventricles.
CRT Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment Insights into the CRT Market, Download a Free Report Sample
CRT Market Segmentation by Regions
The key regions in the CRT market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. North America led the CRT market in 2023. The regional market will experience fast growth in the number of CRT implants during the forecast period due to large elderly population, growing prevalence of HF and the desire to have minimal impact on the overall Cardiac Resynchronisation market.
CRT Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the CRT Market, Download a Free Report Sample
CRT Market - Competitive Landscape
The leading companies in the CRT market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, Biotronik SE & Co KG, MicroPort Scientific Corp, and EBR Systems Inc. Medtronic Plc dominated the CRT market in 2023.
CRT Market Analysis by Companies, 2023 (%)
Buy the Full Report for More About the Leading Companies in the CRT Market, Download a Free Report Sample
Segments Covered in the Report
CRT Segments Outlook (Value, $ Billion, 2015-2033)
- Wireless – Cardiac Resynchronisation Therapy (Wireless-CRT)
- Cardiac Resynchronisation Therapy – Defibrillators (CRT-D)
- Cardiac Resynchronisation Therapy – Pacemakers (CRT-P)
CRT Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East and Africa
Key Inclusions of the market model are –
Currently marketed CRT market and evolving competitive landscape –
- Insightful review of the key industry trends.
- Annualized total CRT market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights –
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the CRT market.
- Competitive dynamics insights and trends provided for the CRT market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Medtronic Plc, Abbott Laboratories, Biotronik SE & Co KG, Boston Scientific Corp, MicroPort Scientific Corp, EBR Systems Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This market model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –
- CMO executives who must have deep understanding of the CRT marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on the CRT market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the CRT market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the CRT market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific CRT market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Abbott Laboratories
Biotronik SE & Co KG
Boston Scientific Corp
MicroPort Scientific Corp
EBR Systems Inc
Others
Frequently asked questions
-
What was the CRT market size in 2023?
The CRT market size was $3.28 billion in 2023.
-
Which was the leading segment in the CRT market?
The Cardiac Resynchronisation Therapy – Defibrillators (CRT-D) segment was leading the CRT market in 2023.
-
Which region dominated the CRT market in 2023?
North America was the largest regional market for CRT implants in 2023.
-
Which are the leading companies in the CRT market?
The leading companies in the CRT market are Medtronic Plc, Abbott Laboratories, Biotronik SE & Co KG, Boston Scientific Corp, MicroPort Scientific Corp, EBR Systems Inc, and Others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.